Refine your search
Collections
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
It is disturbing to see the leading vaccine candidate against tuberculosis (TB) shows a near total lack of efficacy in the recently concluded phase 2b trial in Cape Town, South Africa. The implications of these results are many and enormous - some of them are enlightening and will give us constructive future evidence towards conduct of similar exercises.